emoxypine succinate has been researched along with Depression in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sineglazova, AV; Volchegorskiĭ, IA | 1 |
Faizullin, RM; Kalugina, AV; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, LA | 1 |
Alekseev, MN; Rassokhina, LM; Volchegorskaia, MI; Volchegorskiĭ, IA | 1 |
2 trial(s) available for emoxypine succinate and Depression
Article | Year |
---|---|
[Effect of mexidol (2-ethyl-6-methyl-3-oxypyridine succinate) on the quality of life and depressive symptoms in women with rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Depression; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Picolines; Prospective Studies; Psychotropic Drugs; Quality of Life; Surveys and Questionnaires | 2013 |
[Effect of alpha-lipoic acid and mexidol on neuro- and the affective status in patients at early stages of diabetic foot syndrome].
Topics: Antioxidants; Depression; Diabetic Foot; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mental Competency; Middle Aged; Picolines; Prospective Studies; Severity of Illness Index; Thioctic Acid; Treatment Outcome | 2008 |
1 other study(ies) available for emoxypine succinate and Depression
Article | Year |
---|---|
[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].
Topics: Animals; Anti-Anxiety Agents; Anxiety; Depression; Diabetes Mellitus, Experimental; Humans; Hyperglycemia; Meglumine; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid | 2015 |